Minetaro Ogawa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pulmonary Artery

Hematopoietic Stem Cell

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Stem cells (Dayton, Ohio)

This page only lists publications with an associated author ORCID identifier.

Publications

Saori Morino-Koga, Mariko Tsuruda, Xueyu Zhao, Shogo Oshiro, Tomomasa Yokomizo, Mariko Yamane, Shunsuke Tanigawa, Koichiro Miike, Shingo Usuki, Kei-Ichiro Yasunaga, Ryuichi Nishinakamura, Toshio Suda, Minetaro Ogawa
Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Saori Morino-Koga, Mariko Tsuruda, Xueyu Zhao, Shogo Oshiro, Tomomasa Yokomizo, Mariko Yamane, Shunsuke Tanigawa, Koichiro Miike, Shingo Usuki, Kei-Ichiro Yasunaga, Ryuichi Nishinakamura, Toshio Suda, Minetaro Ogawa
Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Saori Morino-Koga, Mariko Tsuruda, Xueyu Zhao, Shogo Oshiro, Tomomasa Yokomizo, Mariko Yamane, Shunsuke Tanigawa, Koichiro Miike, Shingo Usuki, Kei-Ichiro Yasunaga, Ryuichi Nishinakamura, Toshio Suda, Minetaro Ogawa
Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Tomomasa Yokomizo, Takako Ideue, Saori Morino-Koga, Cheng-Yong Tham, Tomohiko Sato, Naoki Takeda, Yoshiaki Kubota, Mineo Kurokawa, Norio Komatsu, Minetaro Ogawa, Kimi Araki, Motomi Osato, Toshio Suda
Independent origins of fetal liver haematopoietic stem and progenitor cells. Nature 609 (7928) (2022)
Mariko Tsuruda, Saori Morino-Koga, Minetaro Ogawa
Hematopoietic Stem Cell-Independent Differentiation of Mast Cells From Mouse Intraembryonic VE-Cadherin+ Cells. Stem cells (Dayton, Ohio) 40 (3) (2022)